Craniofacial Resection for Malignant Melanoma of the Skull Base

Authors:
  • SPSnehal G. Patel
    Snehal G. Patel
  • BSBhuvanesh Singh
    Bhuvanesh Singh
  • DKDennis H. Kraus
    Dennis H. Kraus
  • PBPatrick G. Bridger
    Patrick G. Bridger
  • GCGiulo Cantu
    Giulo Cantu
  • ACAnthony Cheesman
    Anthony Cheesman
  • GSGeraldo De Sa
    Geraldo De Sa
  • PDPaul Donald
    Paul Donald
  • DFDan M. Fliss
    Dan M. Fliss
  • PGPatrick Gullane
    Patrick Gullane
  • IJIvo Janecka
    Ivo Janecka

Abstract
Mucosal malignant melanoma (MM) is rare and accounts for only 1% of all melanomas.1 Approximately 55% of mucosal melanoma arise in the head and neck, 60% of which are sinonasal in origin (SNMM).2 The most common SNMM sites are the lateral wall and inferior turbinate of the nasal cavity, maxillary sinus, and the ethmoid sinus. Similar to other nasal and paranasal sinus tumors, these tumors often progress asymptomatically and therefore present with late-stage disease. Local extension of these tumors can result in invasion of the skull base. If the disease is localized without evidence of brain invasion, such as many other tumors of this region, the disease may be surgically encompassed by craniofacial resection (CFR). It is widely recognized that CFR for MM has a poor prognosis compared with other malignant skull base tumors.3-5 However, to our knowledge there are no reports in the literature that describe a cohort of patients of sufficient number to carry out statistical analysis to report complications, mortality, and outcome for this individual histologic tumor type. The primary objective of this collaborative study was to examine a relatively large cohort of patients from multiple institutions to determine overall survival (OS), disease-specific survival (DSS), and recurrence-free survival (RFS) as well as mortality and postoperative complications. We also wanted to identify patient and tumor-related predictors of prognosis by multivariate analysis.